Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![MarkBagger Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::741467216.png) Mark-It-Up [@MarkBagger](/creator/twitter/MarkBagger) on x 5137 followers
Created: 2025-07-07 11:20:44 UTC

$COGT XXXX nice news on watch, Cogent Biosciences Announces Positive Top-line Results Achieving Statistical Significance Across All Primary and Key Secondary Endpoints from the SUMMIT Trial of Bezuclastinib in Patients with Non-Advanced Systemic Mastocytosis


XXXXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1942181987504066658/c:line.svg)

**Related Topics**
[statistical significance](/topic/statistical-significance)
[$cogt](/topic/$cogt)

[Post Link](https://x.com/MarkBagger/status/1942181987504066658)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

MarkBagger Avatar Mark-It-Up @MarkBagger on x 5137 followers Created: 2025-07-07 11:20:44 UTC

$COGT XXXX nice news on watch, Cogent Biosciences Announces Positive Top-line Results Achieving Statistical Significance Across All Primary and Key Secondary Endpoints from the SUMMIT Trial of Bezuclastinib in Patients with Non-Advanced Systemic Mastocytosis

XXXXX engagements

Engagements Line Chart

Related Topics statistical significance $cogt

Post Link

post/tweet::1942181987504066658
/post/tweet::1942181987504066658